Postoperative atrial fibrillation (POAF) is prevalent in about 30% to 60% of patients undergoing cardiac surgery, leading to worse outcomes. Botulinum toxin type A (BTX) epicardial injection has been proposed to prevent POAF by impairing cholinergic signaling.
- Provider:A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health
- Activity Link: https://ce.bswhealth.com/node/28296
- Start Date: 2024-03-01 06:00:00
- End Date: 2024-03-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM) - Commercial Support: No
- Activity Type: Journal-based CE
- CME Finder Type: Other
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery, Internal Medicine
Subscribe
Login
0 Comments
Oldest